You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 858 A bispecific antibody targeting CD40 and EpCAM induces superior anti-tumor effects compared to the combination of the monospecific antibodies

Article metrics

Article menu

Download PDFPDF

Late-breaking abstracts
Novel single-agent immunotherapies
858 A bispecific antibody targeting CD40 and EpCAM induces superior anti-tumor effects compared to the combination of the monospecific antibodies

 

Online download statistics by month:

Online download statistics by month: November 2020 to September 2024

AbstractFullPdf
Nov 2020136013
Dec 20202605
Jan 20212405
Feb 202132011
Mar 202172015
Apr 202158011
May 20212608
Jun 20210017
Jul 20210012
Aug 20210011
Sep 20210015
Oct 202146031
Nov 202128021
Dec 20212608
Jan 20223208
Feb 20225006
Mar 202272019
Apr 202276015
May 20225404
Jun 202288017
Jul 2022102012
Aug 202274011
Sep 20228408
Oct 202256015
Nov 20224206
Dec 20225207
Jan 20234409
Feb 20236605
Mar 20232607
Apr 20233609
May 20236804
Jun 20233203
Jul 20232002
Aug 20233401
Sep 20232201
Oct 20232807
Nov 20232805
Dec 20236004
Jan 20242401
Feb 20242603
Mar 20245405
Apr 20245604
May 20243600
Jun 20242200
Jul 20245404
Aug 20245005
Sep 20244001
Total20820391